Watch Days' Supplies and Refills Closely With New Entyvio

Entyvio (en-TIH-vee-oh, vedolizumab) is a new injectable "biologic" for treating ulcerative colitis in adults.

Entyvio reduces inflammation and prevents disease "flare-ups"...similar to other biologics (Remicade, etc).

The big difference is that Entyvio targets inflammation in the colon and reduces the possibility of whole-body or "systemic" side effects (immune system suppression, etc).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote